相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study
Rathika Krishnasamy et al.
BLOOD PURIFICATION (2020)
Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients
Jeong-Hoon Lim et al.
SCIENTIFIC REPORTS (2020)
Medium Cut-Off Dialyzer versus Eight Hemodiafiltration Dialyzers: Comparison Using a Global Removal Score
Francisco Maduell et al.
BLOOD PURIFICATION (2019)
Long-term effect of medium cut-off dialyzer on middle uremic toxins and cell-free hemoglobin
Nam-Jun Cho et al.
PLOS ONE (2019)
Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients
Barbara Pietrzyk et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2019)
Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study
Tae Hoon Kim et al.
BMC NEPHROLOGY (2019)
Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis
Tae-Hwi Schwantes-An et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
Hemodialysis-induced cardiovascular disease
Shadi Ahmadmehrabi et al.
SEMINARS IN DIALYSIS (2018)
Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration
Ana Garcia-Prieto et al.
CLINICAL KIDNEY JOURNAL (2018)
Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease
Cong Zeng et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Performance of hemodialysis with novel medium cut-off dialyzers
Alexander H. Kirsch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Medium cut-off membranes - closer to the natural kidney removal function
Carina Zweigart et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2017)
Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial
Daniel Zickler et al.
PLOS ONE (2017)
Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data
Chang Seong Kim et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2017)
Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Min Young Shin et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Leptin, pre-existing vascular disease, and increased arteriovenous fistula maturation failure in dialysis patients
Jwa-Kyung Kim et al.
JOURNAL OF VASCULAR SURGERY (2016)
Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?
Marcio G. Kiuchi et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2016)
Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients
P. Evenepoel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
Christiane Drechsler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Vincent M. Brandenburg et al.
BMC NEPHROLOGY (2013)
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients
Sophie Liabeuf et al.
KIDNEY INTERNATIONAL (2012)
Resistance to intercompartmental mass transfer limits β2-microglobulin removal by post-dilution hemodiafiltration
RA Ward et al.
KIDNEY INTERNATIONAL (2006)
分享论文
